1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Aneurysm, Ruptured in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S; Hirashima, Y; Kurimoto, M; Takaku, A; Tsukamoto, E | 1 |
| Endo, S; Hirashima, Y; Kobayashi, N; Nukui, H; Takaku, A | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Aneurysm, Ruptured
| Article | Year |
|---|---|
Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety.
Topics: Adult; Aged; Aneurysm, Ruptured; Brain; Clinical Protocols; Dose-Response Relationship, Drug; Female; Humans; Incidence; Injections, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Radiography; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2001 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Aneurysm, Ruptured
| Article | Year |
|---|---|
Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.
Topics: Adult; Aged; Aneurysm, Ruptured; Antibodies, Antiphospholipid; Calcium; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Subarachnoid Hemorrhage | 1994 |